Waning immunity and sub-clinical infection in an epidemic model: Implications for pertussis in The Netherlands

Mathematical Biosciences

Volumn 164, Issue 2, 2000, Pages 161-182

  Van Boven, Michiel ^a   De Melker, Hester E ^a   Schellekens, Joop F P ^a   Kretzschmar, Mirjam ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bordetella pertussis; Communicable disease; Force of infection; Mathematical model; Notification data

Indexed keywords

ARTICLE; BORDETELLA PERTUSSIS; EPIDEMIC; IMMUNITY; INFECTION; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NETHERLANDS; PERTUSSIS;

ADOLESCENT; AGE FACTORS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DISEASE NOTIFICATION; DISEASE OUTBREAKS; HUMANS; INFANT; MODELS, IMMUNOLOGICAL; NETHERLANDS; PERTUSSIS VACCINE; PREVALENCE; TIME FACTORS; VACCINATION; WHOOPING COUGH;

BORDETELLA PERTUSSIS;

EID: 0034039846     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(00)00009-2     Document Type: Article

References (36)

1. H.E. de Melker, M.A.E. Conyn-van Spaendonck, J.F.P. Schellekens, The pertussis epidemic in 1996; description and evaluation based on surveillance data from 1976 to 1996. Report no. 128507005, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, 1997.
2. H.E. de Melker, M.A.E. Conyn-van Spaendonck, H.C. Rümke et al., Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine, Emerging Infect. Diseases 3 (1997) 175.
3. A.D. Bentsi-Enchill, S.A. Halperin, J. Scott et al., Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population, Vaccine 15 (1997) 301.
4. Bass J.W., Wittler R.R. Return of epidemic pertussis in the United States. Pediatric Infect. Disease J. 13:1994;343.
5. C.D.C. Christie, M.L. Marx, C.D. Marchant et al., The 1993 epidemic of pertussis in Cincinatti. Resurgence of disease in a highly immunized population of children, N. Engl. J. Med. 331 (1994) 16.
6. Deen J.L., Mink C.M., Cherry J.D.et al. Household contact study of Bordetella pertussis infections. Clin. Infect. Diseases. 21:1995;1211.
7. Fine P.E.M., Clarkson J.A. Reflections on the efficacy of pertussis vaccines. Rev. Infect. Diseases. 9:1987;866.
8. Fine P.E.M., Clarkson J.A. Distribution of immunity to pertussis in the population of England and Wales. J. Hygiene. 92:1984;21.
9. C.M. Mink, J.D. Cherry, P.D. Christenson et al., A search for Bordetella pertussis infection in university students, Clin. Infect. Diseases 14 (1992) 464.
10. Q.S. He, M.K. Viljanen, S. Nikkari et al., Outcomes of Bordetella pertussis infection in different age groups of an immunized population, J. Infect. Diseases 170 (1994) 873.
11. S. Schmitt-Grohe, J.D. Cherry, U. Heininger et al., Pertussis in German adults, Clin. Infect. Diseases 21 (1995) 860.
12. C.H.W. vonKonig, S. Postels-Multani, H.L. Bock et al., Pertussis in adults: frequency of transmission after household exposure, Lancet 346 (1995) 1326.
13. J.G. DeVille, J.D. Cherry, P.D. Christenson et al., Frequency of unrecognized Bordetella pertussis infections in adults, Clin. Infect. Diseases 21 (1995) 639.
14. S.S. Long, H.W. Lischner, A. Deforest et al., Serologic evidence of subclinical pertussis in immunized children, Pediat. Infect. Disease J. 9 (1990) 700.
15. Long S.S., Welkon C.J., Clark J.L. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J. Infect. Diseases. 161:1990;480.
16. Sutter R.W., Cochi S.L. Pertussis hospitalizations and mortality in the United States 1985-1988. Evaluation of the completeness of national reporting. JAMA. 267:1992;386.
17. H.W. Hethcote, Modeling heterogeneous mixing in infectious disease dynamics, in: V. Isham, G. Medley (Eds.), Models for Infectious Human Diseases, 1996, p. 215.
18. Anderson R.M., May R.M. Infectious Diseases of Humans. Dynamics and Control. 1991;Oxford University, Oxford.
19. de Roos A.M. A gentle introduction to models of physiologically structured populations. Tuljapurkar S., Caswell H. structured-Population Models in Marine, Terrestrial, and Freshwater Systems. 1997;119 Chapman and Hall, New York.
20. de Roos A.M. Numerical methods for structured population models: the Escalator Boxcar Train method. Numer. Meth. Partial Diff. Equations. 4:1988;173.
21. Farrington C.P. The measurement and interpretation of age-specific vaccine efficacy. Int. J. Epidemiol. 21:1992;1014.
22. Ramsay M.E.B., Farrington C.P., Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol. Infect. 111:1993;41.
23. van der Zee A., Agterberg C., Peeters M., Mooi F., Schellekens J.F.P. A clinical validation of Bordetella pertussis and Bordetella parapertussis PCR: comparison with culture and serology using samples of patients suspected for whooping cough from a highly immunized population. J. Infect. Diseases. 174:1996;89.
24. Grenfell B.T., Anderson R.M. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proc. Roy. Soc. London B. 236:1986;213.
25. Hethcote H.W. An age-structured model for pertussis transmission. Math. Biosci. 145:1997;89.
26. A.S. Benenson, Control of Communicable Disease Manual, Am. Public Health Asso., 1995.
27. Grenfell B.T., Anderson R.M. The estimation of age-related rates of infection from case notifications and serological data. J. Hygiene. 95:1985;419.
28. Farrington C.P. Modelling forces of infection for measles, mumps and rubella. Stat. Med. 9:1990;953.
29. Mooi F.R., van Oirschot H., Heuvelman K.et al. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immunol. 66:1998;670.
30. I.H.M. van Loo, H.G.J. van der Heide, N.J.D. Nagelkerke et al., Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population, J. Infect. Diseases 179 (1999) 915.
31. H.E. de Melker, M.A.E. Conyn-van Spaendonck, Immunosurveillance and the evaluation of national immunization programmes: a population based approach, Epidemiol. Infect. 120 (1998) (in press).
32. Cherry J.D. Historical review of pertussis and the classical vaccine. J. Infect. Diseases. 174(S3):1996;S259.
33. He Q.S., Minh N.N.T., Edelman K.et al. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults. Infect. Immunity. 66:1998;3796.
34. N. Guiso, C. Capiau, G. Carletti, et al., Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines, Vaccine 17 (1999) 2366.
35. E.P. Rothstein, E.L. Anderson, M.D. Decker, et al., An acellular pertussis vaccine in healthy adults: Safety and Immunogenicity, Vaccine 17 (1999) 2999.
36. H.H.W. Hethcote, Simulations of pertussis epidemiology in the United States: Effects of adult booster vaccinations, Math. Biosci. 158 (1999) 47.